Charles S. Mayo

Charles S. Mayo

Auto-generated profile, based on publicly available information

Charles S. Mayo

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
CMCharles S. Mayo
Charles S. Mayo
JMJean M. Moran
Jean M. Moran
WBWalter Bosch
Walter Bosch
YXYing Xiao
Ying Xiao
TMTodd McNutt
Todd McNutt
TYTorunn I. Yock
Torunn I. Yock
A substantial barrier to the single- and multi-institutional aggregation of data to supporting clinical trials, practice quality improvement efforts, and development of big data analytics resource systems is the lack of standardized nomenclatures for expressing dosimetric data. To address this issue, the American Association of Physicists in Medicine (AAPM) Task Group 263 was charged with providing nomenclature guidelines and values in radiation oncology for use in clinical trials, data-pooling initiatives, population-based studies, and routine clinical care by standardizing: (1) structure names across image processing and treatment planning system platforms; (2) nomenclature for dosimetric data (eg, dose-volume histogram [DVH]-based metrics); (3) templates for clinical trial groups and users of an initial subset of software platforms to facilitate adoption of the standards; (4) formalism for nomenclature schema, which can accommodate the addition of other structures defined in the future. A multisociety, multidisciplinary, multinational group of 57 members representing stake holders ranging from large academic centers to community clinics and vendors was assembled, including physicists, physicians, dosimetrists, and vendors. The stakeholder groups represented in the membership included the AAPM, American Society for Radiation Oncology (ASTRO), NRG Oncology, European Society for Radiation Oncology (ESTRO), Radiation Therapy Oncology Group (RTOG), Children's Oncology Group (COG), Integrating Healthcare Enterprise in Radiation Oncology (IHE-RO), and Digital Imaging and Communications in Medicine working group (DICOM WG); A nomenclature system for target and organ at risk volumes and DVH nomenclature was developed and piloted to demonstrate viability across a range of clinics and within the framework of clinical trials. The final report was approved by AAPM in October 2017. The approval process included review by 8 AAPM committees, with additional review by ASTRO, European Society for Radiation Oncology (ESTRO), and American Association of Medical Dosimetrists (AAMD). This Executive Summary of the report highlights the key recommendations for clinical practice, research, and trials.

1 October 2016 in Advances in Radiation Oncology
Verified
Journal Article
Open access
CMCharles S. Mayo
Charles S. Mayo
MKMarc L. Kessler
Marc L. Kessler
AEAvraham Eisbruch
Avraham Eisbruch
GWGrant Weyburne
Grant Weyburne
MFMary Feng
Mary Feng
RHRandall K. Ten Haken
Randall K. Ten Haken
Although large volumes of information are entered into our electronic health care records, radiation oncology information systems and treatment planning systems on a daily basis, the goal of extracting and using this big data has been slow to emerge. Development of strategies to meet this goal is aided by examining issues with a data farming instead of a data mining conceptualization. Using this model, a vision of key data elements, clinical process changes, technology issues and solutions, and role for professional societies is presented. With a better view of technology, process and standardization factors, definition and prioritization of efforts can be more effectively directed.

26 May 2023 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
CMCharles S. Mayo
Charles S. Mayo
MFMary U. Feng
Mary U. Feng
KBKristy K. Brock
Kristy K. Brock
RKRandi Kudner
Randi Kudner
PBPeter Balter
Peter Balter
YXYing Xiao
Ying Xiao
The ongoing lack of data standardization severely undermines the potential for automated learning from the vast amount of information routinely archived in electronic health records (EHRs), radiation oncology information systems, treatment planning systems, and other cancer care and outcomes databases. We sought to create a standardized ontology for clinical data, social determinants of health, and other radiation oncology concepts and interrelationships. The American Association of Physicists in Medicine's Big Data Science Committee was initiated in July 2019 to explore common ground from the stakeholders' collective experience of issues that typically compromise the formation of large inter- and intra-institutional databases from EHRs. The Big Data Science Committee adopted an iterative, cyclical approach to engaging stakeholders beyond its membership to optimize the integration of diverse perspectives from the community. We developed the Operational Ontology for Oncology (O3), which identified 42 key elements, 359 attributes, 144 value sets, and 155 relationships ranked in relative importance of clinical significance, likelihood of availability in EHRs, and the ability to modify routine clinical processes to permit aggregation. Recommendations are provided for best use and development of the O3 to 4 constituencies: device manufacturers, centers of clinical care, researchers, and professional societies. O3 is designed to extend and interoperate with existing global infrastructure and data science standards. The implementation of these recommendations will lower the barriers for aggregation of information that could be used to create large, representative, findable, accessible, interoperable, and reusable data sets to support the scientific objectives of grant programs. The construction of comprehensive "real-world" data sets and application of advanced analytical techniques, including artificial intelligence, holds the potential to revolutionize patient management and improve outcomes by leveraging increased access to information derived from larger, more representative data sets.

31 August 2017 in Frontiers in Oncology
Verified
Journal Article
Open access
CMCharles S. Mayo
Charles S. Mayo
MMMartha M. Matuszak
Martha M. Matuszak
MSMatthew J. Schipper
Matthew J. Schipper
SJShruti Jolly
Shruti Jolly
JHJames A. Hayman
James A. Hayman
RHRandall K. Ten Haken
Randall K. Ten Haken
Emergence of Big Data Analytics Resource Systems (BDARSs) as a part of routine practice in Radiation Oncology is on the horizon. Gradually, individual researchers, vendors and professional societies are leading initiatives to create and demonstrate use of automated systems. What are the implications for design of clinical trials, as these systems emerge? Gold standard, randomized controlled trials (RCTs) have high internal validity for the patients and settings fitting constraints of the trial, but also have limitations including: reproducibility, generalizability to routine practice, infrequent external validation, selection bias, characterization of confounding factors, ethics, and use for rare events. BDARS present opportunities to augment and extend RCTs. Preliminary modeling using single and muti-institutional BDARS may lead to better design and less cost. Standardizations in data elements, clinical processes and nomenclatures used to decrease variability and increase veracity needed for automation and multi-institutional data pooling in BDARS also support ability to add clinical validation phases to clinical trial design and increase participation. However, volume and variety in BDARS present other technical, policy and conceptual challenges including applicable statistical concepts, cloud based technologies. In this summary, we will examine both the opportunities and the challenges for use of Big Data in design of clinical trials.

12 March 2025 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
CMCharles S. Mayo
Charles S. Mayo
AAAne L. Appelt
Ane L. Appelt
KPKelly C. Paradis
Kelly C. Paradis
LDLaura A. Dawson
Laura A. Dawson
NANicolaus Andratschke
Nicolaus Andratschke
SYSue S. Yom
Sue S. Yom

1 July 2016 in Practical Radiation Oncology
Verified
Journal Article
Closed access
CMCharles S. Mayo
Charles S. Mayo
TPThomas M. Pisansky
Thomas M. Pisansky
IPIvy A. Petersen
Ivy A. Petersen
EYElizabeth S. Yan
Elizabeth S. Yan
BDBrian J. Davis
Brian J. Davis
MHMichael G. Haddock
Michael G. Haddock